Accelerate Diagnostics Inc (AXDX) - Financial and Strategic SWOT Analysis Review

March 2021 | 45 pages | ID: AA0F2984A6BEN
GlobalData

Abstracts

Accelerate Diagnostics Inc (AXDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company that carries out the development and commercialization of instruments for the identification and testing of antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, a platform for the identification (ID) and antibiotic susceptibility testing (AST) of infectious pathogens; and Accelerate PhenoTest BC kit which provides ID and AST results for patients with bacteremia or fungemia. The company has a manufacturing facility in Tucson Arizona. It sells products directly and also through a network of third-party distributors to hospital microbiology laboratories in domestic and foreign countries. Accelerate is headquartered in Tucson, Arizona, the US.

Accelerate Diagnostics Inc Key Recent Developments

Feb 23,2021: Accelerate Diagnostics reports fourth quarter and full-year 2020 financial results
Feb 01,2021: Accelerate Diagnostics schedules call to review 2020 fourth quarter and full year results
Jan 12,2021: Accelerate Diagnostics announces preliminary fourth quarter and full-year 2020 financial results
Nov 05,2020: Accelerate Diagnostics reports third quarter 2020 financial results
Aug 24,2020: Accelerate Diagnostics names Nedal Safwat chief strategy officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Accelerate Diagnostics Inc - Key Facts
Accelerate Diagnostics Inc - Key Employees
Accelerate Diagnostics Inc - Key Employee Biographies
Accelerate Diagnostics Inc - Major Products and Services
Accelerate Diagnostics Inc - History
Accelerate Diagnostics Inc - Company Statement
Accelerate Diagnostics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Accelerate Diagnostics Inc - Business Description
Geographical Segment: Domestic
Performance
Geographical Segment: Foreign
Performance
R&D Overview
Accelerate Diagnostics Inc - SWOT Analysis
SWOT Analysis - Overview
Accelerate Diagnostics Inc - Strengths
Accelerate Diagnostics Inc - Weaknesses
Accelerate Diagnostics Inc - Opportunities
Accelerate Diagnostics Inc - Threats
Accelerate Diagnostics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Accelerate Diagnostics Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Accelerate Diagnostics Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 23, 2021: Accelerate Diagnostics reports fourth quarter and full-year 2020 financial results
Feb 01, 2021: Accelerate Diagnostics schedules call to review 2020 fourth quarter and full year results
Jan 12, 2021: Accelerate Diagnostics announces preliminary fourth quarter and full-year 2020 financial results
Nov 05, 2020: Accelerate Diagnostics reports third quarter 2020 financial results
Aug 24, 2020: Accelerate Diagnostics names Nedal Safwat chief strategy officer
Aug 06, 2020: Accelerate Diagnostics reports second quarter 2020 financial results & announces new product offering
May 07, 2020: Accelerate Diagnostics Announces Preliminary First Quarter Financial Results and Provides COVID-19 Business Updates; Schedules First Quarter 2020 Financial Results Conference Call for May 7, 2020
Apr 15, 2020: Accelerate Diagnostics announces preliminary first quarter financial results and provides covid-19 business updates; schedules first quarter 2020
Apr 14, 2020: Accelerate Diagnostics receives loan under Paycheck Protection Program
Feb 27, 2020: Accelerate Diagnostics reports fourth quarter 2019 financial results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Accelerate Diagnostics Inc, Key Facts
Accelerate Diagnostics Inc, Key Employees
Accelerate Diagnostics Inc, Key Employee Biographies
Accelerate Diagnostics Inc, Major Products and Services
Accelerate Diagnostics Inc, History
Accelerate Diagnostics Inc, Subsidiaries
Accelerate Diagnostics Inc, Key Competitors
Accelerate Diagnostics Inc, Ratios based on current share price
Accelerate Diagnostics Inc, Annual Ratios
Accelerate Diagnostics Inc, Annual Ratios (Cont...1)
Accelerate Diagnostics Inc, Interim Ratios
Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Accelerate Diagnostics Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Accelerate Diagnostics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Accelerate Diagnostics Inc, Performance Chart (2016 - 2020)
Accelerate Diagnostics Inc, Ratio Charts
Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Accelerate Diagnostics Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021